Tejnaksh Healthcare Share Price Live
Live Tejnaksh Healthcare Share Price Chart
Tejnaksh Healthcare Performance
Days Range
| Previous Close | ₹15.95 |
|---|---|
| Open | ₹15.99 |
| Volume | 17,912 |
| Day's Range | ₹14.01 - ₹15.99 |
|---|---|
| 52W Range | ₹14.01 - ₹29.50 |
| Market Cap | ₹32.40 Cr |
Tejnaksh Healthcare Fundamentals
| ROCE(TTM) | 9.29 |
|---|---|
| P/E Ratio (TTM) | 21.27 |
| P/B Ratio | 1.22 |
| Industry P/E | 59.77 |
| Debt to Equity | 0.04 |
| ROE | 6.34 |
| EPS (TTM) | 0.83 |
| Dividend Yield | 0 |
| Book Value | 13.04 |
| Face Value | 5 |
| ROCE(TTM) | 9.29 |
|---|---|
| P/E Ratio (TTM) | 21.27 |
| P/B Ratio | 1.22 |
| Industry P/E | 59.77 |
| Debt to Equity | 0.04 |
| ROE | 6.34 |
|---|---|
| EPS (TTM) | 0.83 |
| Dividend Yield | 0 |
| Book Value | 13.04 |
| Face Value | 5 |
Tejnaksh Healthcare Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 3.19 | 3.21 | 2.64 | 2.98 |
| Expenses | 2.26 | 2.68 | 2.40 | 2.55 |
| Profit before tax | 0.97 | 0.59 | 0.29 | 0.49 |
| Operating Profit | 0.56 | 0.42 | 0.21 | 0.33 |
| Net Profit | 0.56 | 0.42 | 0.21 | 0.33 |
| ESP in Rs | 0.38 | 0.21 | 0.12 | 0.15 |
Tejnaksh Healthcare Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 73.83% | 73.83% | 73.83% | 73.83% | 73.83% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0% | 0% | 0% | 0% | 0% |
| Public | 26.17% | 26.17% | 26.17% | 26.17% | 26.17% |
About Tejnaksh Healthcare
Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a complete range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate.
Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Company's achievements were the multiple records that motivates the customers to improve treatment for Urology.
In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination.
In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/- each by raising funds aggregating to Rs. 2.44 Crores.
In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism.
In 2016, Company set up the first indigenous PCNL simulation lab in the country and were made commercially available. Further, Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center at Navi Mumbai in 2016.
Parent Organisation
Indian Private
Managing Director
Ashish Vishwas Rawandale
Founded
2008
NSE Symbol
Top Mutual Funds Invested in Tejnaksh Healthcare Share
Top Mutual Funds Invested in Tejnaksh Healthcare Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Max Healthcare Institute Ltd | 1,082.0 4.90 (0.45%) | ₹1,04,747.80 | 940.05 - 1,314.3![]() |
| Apollo Hospitals Enterprise Ltd | 7,007.0 -11.50 (-0.16%) | ₹1,00,923.89 | 6,001.0 - 8,099.5![]() |
| Fortis Healthcare Ltd | 855.5 2.55 (0.30%) | ₹64,397.93 | 577.0 - 1,104.3![]() |
| Narayana Hrudayalaya Ltd | 1,881.9 24.30 (1.31%) | ₹37,969.22 | 1,256.55 - 2,370.2![]() |
| Aster DM Healthcare Ltd | 616.5 -13.30 (-2.11%) | ₹32,654.58 | 387.1 - 732.2![]() |
| Global Health Ltd | 1,147.7 -9.30 (-0.80%) | ₹31,113.83 | 996.45 - 1,456.5![]() |
Popular stocks
Tejnaksh Healthcare Ltd FAQs
What is the share price of Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) shares?
Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) share price as of December 11, 2025, on NSE is Rs 14.68 (NSE) and Rs 14.68 (BSE) on BSE.
Can I buy Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) from Angel One?
Yes, You can buy Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) shares by opening a Demat account with Angel One.
How do I buy Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) from Angel One?
Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) shares.
1. Direct investment: You can buy Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Tejnaksh Healthcare Ltd (Tejnaksh Healthcare Ltd) shares.




